Status:
COMPLETED
Type Distribution of Human Papillomavirus in Adult African Women Diagnosed With Invasive Cervical Cancer
Lead Sponsor:
GlaxoSmithKline
Collaborating Sponsors:
University of Cape Town
African Organization for Research and Training in Cancer (AORTIC)
Conditions:
Infections, Papillomavirus
Cervical Cancer
Eligibility:
FEMALE
21+ years
Brief Summary
The aim of the study is to assess the distribution of the most frequent types of human papillomavirus in African women diagnosed with invasive cervical cancer.
Eligibility Criteria
Inclusion
- A female aged 21 years or more, presenting with a lesion macroscopically suggestive of invasive cervical cancer.
- Scheduled for cervical biopsy as per routine procedure at the participating institution on the day of the visit or on a later date.
- Written or oral-witnessed informed consent obtained from the subject prior to any study procedure.
- No prior chemo- or radiotherapy for cervical cancer.
Exclusion
- Not applicable
Key Trial Info
Start Date :
October 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
591 Patients enrolled
Trial Details
Trial ID
NCT01207999
Start Date
October 1 2007
End Date
March 1 2010
Last Update
November 22 2012
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Accra, Ghana
2
GSK Investigational Site
Kumasi, Ghana
3
GSK Investigational Site
Ibadan, Nigeria
4
GSK Investigational Site
Lagos, Nigeria